AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
ImmunoassayMedical OncologyOncology NursingImmunoenzyme TechniquesRadiation OncologyOncology Service, HospitalFluorescence Polarization ImmunoassayEnzyme Multiplied Immunoassay TechniqueEconomic CompetitionHealth Care SectorNeoplasmsSensitivity and SpecificityCommerceMarketingReagent Kits, DiagnosticEnzyme-Linked Immunosorbent AssayMarketing of Health ServicesInvestmentsUnited StatesFluoroimmunoassayCross ReactionsRadiotherapy DosageVaccines, DNAAntineoplastic Combined Chemotherapy ProtocolsDrug IndustryCancer Care FacilitiesTreatment OutcomeRadioimmunoassayImmunoglobulin GEvaluation Studies as TopicAntibodies, MonoclonalCombined Modality TherapyClinical Trials as TopicDose FractionationAntibodies, ViralAntineoplastic AgentsFalse Positive ReactionsReproducibility of ResultsRadiotherapy, Intensity-ModulatedSocieties, MedicalAutoanalysisLuminescent MeasurementsSubstance Abuse DetectionAIDS VaccinesDrug ApprovalTime FactorsDisease-Free SurvivalQuality ControlHealth Facility MergerSurvival AnalysisRadiotherapyNephelometry and TurbidimetryAntitrust LawsNeoplasm StagingEuropiumAntibody SpecificityRadiotherapy Planning, Computer-AssistedPrognosisCisplatinBrachytherapyHematologyFalse Negative ReactionsBreast NeoplasmsGas Chromatography-Mass SpectrometryInsurance PoolsDrug Administration ScheduleVaccinationRetrospective StudiesImmunoglobulin MLegislation, DrugSurvival RateAntibodies, ImmobilizedAntibodies, BacterialReference StandardsClinical Trials, Phase I as TopicRadiotherapy, AdjuvantLung NeoplasmsPalliative CareGenital Neoplasms, FemaleAntibodiesClinical Trials, Phase III as TopicUnited States Food and Drug AdministrationInsurance Selection BiasHealth Care ReformNeoplasm Recurrence, LocalHIV AntibodiesLatex Fixation TestsVincristineFecesGovernment RegulationProspective StudiesDigoxinFeasibility StudiesCost ControlModels, EconomicAntigens, ViralFinancial ManagementPatents as TopicBiological MarkersCalibration
2022Assays2021Precision oncologyMass spectrometryThermo Fisher SciGenomicForecast period2020PandemicNorth AmericaTrendsReagentsDiagnosticElectrophoresisTechnological advancementsMeticulous Market Research PvtMolecularAdvancementsGeriatric populationCAGRHospitalsImmunodiagnosticsSegmentOutcomesConcentrationDiagnostics marketDynamicsRestrictEarly diagnosisInfectious DiseasePatientsLaboratoryCompetitive LandscapeContinuousApplicationCompanionLaboratoriesAnalyzersGloballyProduct2026DetectionClinicalReportAnalysisChallengesPrevalenceTechnologyBillionTestsPlayersRevenueFactors
202211
  • NEW YORK , July 28, 2023 /PRNewswire/ - The immunodiagnostics market size is set to grow by USD 22,669.75 million between 2022 and 2027 and register an accelerating CAGR of 12% , according to Technavio's latest market research report estimates. (countyenews.com)
  • The global clinical laboratory service market size was estimated at USD 217.53 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030. (grandviewresearch.com)
  • For instance, in March 2022, Illumina Inc. launched TruSight oncology, a single test that can determine the precise genetic makeup of a patient's cancer by evaluating various tumor genes and biomarkers. (grandviewresearch.com)
  • The global in vitro diagnostic market size was valued at USD 132.95 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of -2.8 % from 2023 to 2030. (grandviewresearch.com)
  • For instance, in March 2022, Ion Torrent Genexus Dx Integrated Sequencer was introduced in the market by Thermo Fisher Scientific for research as well as diagnostic purposes. (grandviewresearch.com)
  • The molecular diagnostics application segment held the highest market share of 40.92% in 2022 owing to the launch of novel products and continuous evolution in technology. (grandviewresearch.com)
  • The US esoteric testing market size was valued at USD 7.49 Billion in 2022 and is projected to reach USD 13.43 Billion by 2031 , expanding at a CAGR of 6.7% during the forecast period 2023 - 2031 . (growthmarketreports.com)
  • The companion animal diagnostics market study presents historical market data in terms of value (2020 and 2021), estimated current data (2022), and forecasts for 2029 - by product, technology, animal type, and end user. (chatsdumonde.net)
  • Based on technology, the immunodiagnostics segment is estimated to account for the largest share of this market in 2022. (chatsdumonde.net)
  • Based on product, the consumables segment is estimated to dominate the companion animal diagnostics market in 2022. (chatsdumonde.net)
  • The global immunoglobulins market size will grow from $15.89 billion in 2022 to $17.16 billion in 2023 at a compound annual growth rate (CAGR) of 8.0% . (thebusinessresearchcompany.com)
Assays5
  • The company has further announced the development of a line of assays for hemato-oncology and genomic profiling using the system, which is anticipated to enhance the adoption of the system. (grandviewresearch.com)
  • As a result, the cancer in vitro diagnostics (IVD) market is valued at $5,535 million* ($5.5 billion) in 2021, including the demand for companion assays, according to World Market for Cancer Diagnostics , a new report by leading medical market research publisher Kalorama Information. (kaloramainformation.com)
  • Liquid biopsies are blood-based molecular tumor assays, which have been on the market for several years. (kaloramainformation.com)
  • Furthermore, growth in biotechnology and biopharmaceutical industries coupled with the emerging trend of smartphone-based formats and multiplex bead assays are creating a positive outlook for the market. (postingtree.com)
  • Moreover, the emergence of various PoC tests and assays is expected to create significant growth opportunities. (chatsdumonde.net)
20214
  • However, there was a decrease in routine testing during the first quarter of 2021 due to the lockdown, but the industry has gradually begun to witness growth owing to increased testing volume for COVID-19. (grandviewresearch.com)
  • The In-Vitro Diagnostics/IVD Market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. (jaipurherald.in)
  • According to the latest report by IMARC Group, titled " Immunoassay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ," offers a comprehensive analysis of the industry, which comprises insights on immunoassay market research report . (postingtree.com)
  • North America is likely to dominate the pharmacogenomics market during 2021-2028. (theinsightpartners.com)
Precision oncology1
  • In December 2020, Merck KGaA (Germany) collaborated with Artios Pharma Limited (U.K.) to develop and identify precision oncology drug candidates. (meticulousresearch.com)
Mass spectrometry1
  • Specialty immunoassays, continuous glucose tests, mass spectrometry and inherited diseases are other large and high-growth segments. (bioinfoinc.com)
Thermo Fisher Sci1
  • Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott (US), and Thermo Fisher Scientific (US) are the leading players in this market. (jaipurherald.in)
Genomic1
  • The growing advances in proteomic and genomic sciences have boosted the emergence of personalized therapies. (meticulousresearch.com)
Forecast period18
  • The market share growth by the reagents and consumables segment is significant during the forecast period. (countyenews.com)
  • hence, such factors are expected to fuel the growth of this segment which in turn will drive the market during the forecast period. (countyenews.com)
  • The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. (countyenews.com)
  • The rising demand for biomarker-based tests drives the global immunodiagnostics market growth during the forecast period. (countyenews.com)
  • Hence, such factors are expected to replace traditional drug therapy with personalized devices, which in turn is expected to drive the immunodiagnostics market growth during the forecast period. (countyenews.com)
  • The increase in demand for personalized medicine is a primary trend in the global immunodiagnostics market during the forecast period. (countyenews.com)
  • Moreover, rapid advancements in data management and sample preparation due to the growing volumes of testing samples are anticipated to boost industry growth during the forecast period. (grandviewresearch.com)
  • However, the adoption of at-home testing is expected to hamper the industry growth in the forecast period. (grandviewresearch.com)
  • The region is expected to retain its dominance growing at the second-fastest CAGR during the forecast period owing to the extensive R&D initiatives being undertaken by major market players for the development of novel reagents. (grandviewresearch.com)
  • For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market. (openpr.com)
  • However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the forecast period. (jaipurherald.in)
  • Oncology segment is expected to witness the fastest growth in the forecast period. (jaipurherald.in)
  • Increasing use of molecular diagnostics and genomics & proteomics technologies are some of the factors that can boost the market growth during the forecast period. (growthmarketreports.com)
  • The global Point of Care (PoC) diagnostics market was valued at USD 18.91 billion in 2020 and is expected to reach US$ 24.70 billion by 2028 to grow at a CAGR of 3.4% during the forecast period. (medgadget.com)
  • The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. (theinsightpartners.com)
  • Also, the support of the regulatory agencies is expected to drive the market in the US during the forecast period. (theinsightpartners.com)
  • Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period. (thebusinessresearchcompany.com)
  • Further, during the forecast period, the presence of limited key players in the market is expected to offer significant growth opportunities to the market players to expand their customer base, especially in developing countries. (theinsightpartners.com)
20205
  • The reagents & kits segment accounted for the largest share of 68.1% of the market in 2020. (jaipurherald.in)
  • In 2020, infectious diseases accounted for 34.1% of the IVD market. (jaipurherald.in)
  • Clinics were the largest end-use segment accounting for major market share in 2020. (medgadget.com)
  • North America was the largest regional market for revenue generation in from Point of Care (PoC) devices in 2020. (medgadget.com)
  • The global immunoassay market witnessed strong growth during 2015-2020. (postingtree.com)
Pandemic5
  • The growth can be attributed to the increasing adoption of IVD owing to the rise in testing due to the pandemic. (grandviewresearch.com)
  • The COVID-19 pandemic has increased the awareness about the infectious disease and encouraged people for early diagnosis, positively influencing the market growth. (growthmarketreports.com)
  • As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic. (postingtree.com)
  • Importantly, serology tests have become an important part of the global response to the COVID-19 pandemic. (wikipedia.org)
  • The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. (thebusinessresearchcompany.com)
North America3
  • This report focuses on Immunodiagnostics Market Size, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. (openpr.com)
  • The global task trainers market is further segmented by geography into four major continents namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). (meticulousresearch.com)
  • North America is one of the most important regions for adopting and growing new technologies due to flattering government policies to boost innovation, a vast industrial base, and high purchasing power, mainly in developed countries such as the US and Canada. (theinsightpartners.com)
Trends3
  • This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. (countyenews.com)
  • World Market for Cancer Diagnostics identifies several significant trends occurring in the cancer IVD market currently, spanning a range of aspects and subjects from technology trends to regulatory trends. (kaloramainformation.com)
  • The report on the US esoteric testing market includes an assessment of the market, trends, segments and regional markets. (growthmarketreports.com)
Reagents6
  • There is an increasing demand for reagents and consumables segment due to the rising demand for high-throughput screening with the help of immunoassays which has resulted in the production of new reagents to detect antigens. (countyenews.com)
  • Furthermore, there is a rise in the implementation of fluorescence and chemiluminescence technology with new reagents which has fuelled the growth of this segment. (countyenews.com)
  • The growth in precision medicine is projected to enhance the overall demand for such novel reagents and consumables. (grandviewresearch.com)
  • Reagents & kits segment accounted for the largest share in the In-Vitro Diagnostics/IVD Market. (jaipurherald.in)
  • Based on product and service, the In-Vitro Diagnostics Market is segmented into reagents & kits, instruments, services, and data management software. (jaipurherald.in)
  • Accessibility to a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases and genetic disorders in the early stages are expected to drive the growth of this segment. (jaipurherald.in)
Diagnostic5
  • The industry is witnessing growth due to factors, such increasing burden of chronic diseases and the growing demand for early diagnostic tests. (grandviewresearch.com)
  • FoundationOne CDx's approval as the first FDA approved companion diagnostic test for solid tumors is a positive signal to companies developing companion diagnostics for oncology indications. (bioinfoinc.com)
  • The leading players in the point of care (PoC) diagnostic market include Sekisui Diagnostics LLC, Trinity Biotech PLC, International Technidyne Corporation (ITC), Nipro Diagnostics Inc, Becton Dickinson & Company, Danaher Corporation, Siemens Healthcare GmbH, Roche Ltd. (medgadget.com)
  • Factors contributing to the large share of this segment include the growing adoption of diagnostic products based on immunodiagnostic technology and the development of advanced diagnostic immunoassay tests. (chatsdumonde.net)
  • The acquisition expands PerkinElmer's reach into autoimmune and allergy diagnostic markets, while offering new infectious disease capabilities for customers in China. (clpmag.com)
Electrophoresis1
  • Techniques, such as spectrophotometry, immunoassay, and electrophoresis, are used to measure the concentration of different types of molecules present in the collected sample. (grandviewresearch.com)
Technological advancements3
  • Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be among the major drivers of this market. (grandviewresearch.com)
  • Moreover, ongoing technological advancements is driving the market growth. (growthmarketreports.com)
  • In addition to this, technological advancements in the field of immunoassays offering expedited results with higher efficacy, detection limits, sensitivity, and cost-efficiency are contributing to the market growth. (postingtree.com)
Meticulous Market Research Pvt1
Molecular1
  • This trend is well established in clinical chemistry and hematology disciplines and is now extending to other areas, including immunoassays and molecular diagnostics. (jaipurherald.in)
Advancements1
  • The report also includes competitor and regional analysis, and contemporary advancements in the global market. (postingtree.com)
Geriatric population4
  • The rise in the geriatric population and growth in knowledge regarding early testing has led to a surge in the number of regular check-ups, as a majority of deaths due to infections and chronic conditions occur in the population aged over 75 years. (grandviewresearch.com)
  • The growth of the In-Vitro Diagnostics/IVD Market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. (jaipurherald.in)
  • The Rising Geriatric Population and the Growing Burden of Chronic Diseases are Driving the Global Digital. (meticulousresearch.com)
  • The increasing geriatric population drives the growth of the immunoglobulins market. (thebusinessresearchcompany.com)
CAGR1
Hospitals2
  • The development of automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses is expected to fuel the market growth. (grandviewresearch.com)
  • The market is further segmented by end user in to healthcare education, hospitals, military, emergency medical services , and voluntary organizations. (meticulousresearch.com)
Immunodiagnostics3
  • Furthermore, the report offers a detailed analysis and information as per Immunodiagnostics Market Size Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. (openpr.com)
  • The Immunodiagnostics Market Size report examines competitive scenario by analyzing key players in the market. (openpr.com)
  • Major countries in each region are mapped according to individual Immunodiagnostics Market Size revenue. (openpr.com)
Segment3
  • The growth in self-monitoring of blood glucose, which is by far the largest segment of POC testing, is in part a testament to this need for more convenient and effective care. (jaipurherald.in)
  • The infectious disease testing segment is anticipated to account for a large market shares due to increasing demand for diagnosis of diseases caused by pathogenic organisms such as viruses, bacteria, fungi, or parasites. (growthmarketreports.com)
  • Factors driving the growth of this segment include the increasing canine population as pets and the growing prevalence of diseases such as diabetes. (chatsdumonde.net)
Outcomes1
  • In addition, growing emphasis on patient safety and outcomes further drives the global task trainer market since it addresses a long standing concern of medical errors in healthcare practices. (meticulousresearch.com)
Concentration3
  • Immunoassay (IA) is a biochemical technique used to measure the concentration or presence of macromolecules analytes in a solution through an antibody or an antigen. (postingtree.com)
  • The immunoassay instruments help in detecting the concentration and presence of analytes in the blood, plasma and urine samples. (postingtree.com)
  • The IgY concentration changed down in immunoassays using biotin-avidin/streptavidin. (preprints.org)
Diagnostics market2
  • Thus, growing awareness regarding personalized medicines and active R&D in the area of personalized medicines is expected positively impact the field of cancer care, thereby driving the tissue diagnostics market. (meticulousresearch.com)
  • The global Point of Care (PoC) diagnostics market is driven by continuous technological advancement in the form of miniaturization of devices, growing preference of patients towards home care, and consistent decline in prices due to inflow of innovative market players. (medgadget.com)
Dynamics1
  • gives a detailed insight into current market dynamics and provides analysis on future market growth. (medgadget.com)
Restrict3
  • Comprehensive analysis of factors that drive and restrict the market growth is provided. (openpr.com)
  • Lack of awareness about the tests can restrict the market expansion in the projected timeline. (growthmarketreports.com)
  • However, the increased risk of attention deficit hyperactivity disorder (ADHD) and other complications in pregnancy restrict the growth of the market. (theinsightpartners.com)
Early diagnosis2
  • Moreover, there is an increasing demand for personalized care with accurate and early diagnosis in oncology. (grandviewresearch.com)
  • The growth of the market is attributed to increasing awareness regarding early diagnosis of rare diseases. (growthmarketreports.com)
Infectious Disease1
  • Concern over sepsis and respiratory conditions should ensure that infectious disease will remain in the fast-growth categories. (bioinfoinc.com)
Patients3
  • The urgent need to improve the outcome of patients with various forms of cancer is boosting opportunities for new and existing tests that help detect tumors early, determine disease risk, identify and assess the effectiveness of therapies, and assist in the discovery and commercialization of new improved anti-cancer agents. (kaloramainformation.com)
  • Other key factors that drives task trainer market includes consistent development in medical simulation technologies, shortage of real life patients for practice purpose, and growing preference to minimal invasive surgeries. (meticulousresearch.com)
  • However, there are certain factors that have restraining effect on this market such as fidelity of task trainer, which is nothing but the inability of task trainers to imitate the emotional attributes of the patients. (meticulousresearch.com)
Laboratory1
  • All image credit: Colder Product Company The in vitro diagnostics (IVD) market continues to grow at an almost breakneck pace, along with laboratory demands for increasingly complex and efficient equipment. (cytofluidix.com)
Competitive Landscape1
  • The report has also analysed the competitive landscape of the market with some of the key players being. (postingtree.com)
Continuous1
  • Der Datenschutzbeauftragte des Landes Bremen forderte die Effective in controlling the clinical and growth-limiting effects of respiratory disease as continuous http://abadiepaper.com/__media__/js...r/g5/bbs/board.php?bo_table=free&wr_id=606093 Franklin won by Wiradjuri author Tara June Winch for novel of family, history and language. (noichuyenhay.com)
Application2
  • This report categorizes the market based on manufacturers, regions, type and application. (openpr.com)
  • Our report has categorized the market based on region, technology, product, application and end use. (postingtree.com)
Companion1
  • This proliferating cancer threat is boosting world demand and growth opportunities for specific, sensitive tests, as well as precision medicine and companion diagnostics for treating cancer. (kaloramainformation.com)
Laboratories1
  • The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. (thebusinessresearchcompany.com)
Analyzers1
  • Siemens Healthineers announced today the CE Mark and global commercial availability of its Atellica™ Solution-flexible, scalable, automation-ready immunoassay and chemistry analyzers. (cytofluidix.com)
Globally1
  • Developed markets still make up the bulk of revenue in IVD (N.America, Europe, Japan are 72% of market), but vendors compete globally and seek out emerging markets to thrive. (bioinfoinc.com)
Product2
  • The global task trainers market is mainly segmented by product, end-user, and geography. (meticulousresearch.com)
  • The product market is primarily segmented into obstetric trainers, pediatric & neonatal care trainers, trauma care kits and trainers, respiratory & airway trainers, basic life support trainers, and simulation accessories. (meticulousresearch.com)
20261
  • Global demand for circulating tumor cell (CTC) testing products is projected to rise 6% annually through 2026. (kaloramainformation.com)
Detection2
  • Moreover, for the detection of newer infections, such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry. (grandviewresearch.com)
  • With the acquisition of EuroImmun and its talented team of professionals, we are able to leverage our combined advanced detection, imaging, and assay development capabilities, along with our strong collective market positions and synergistic commercial activities, to deliver better and more-complete solutions to our customers around the world," says Robert Friel, chairman and CEO of PerkinElmer. (clpmag.com)
Clinical1
  • The report includes an in-depth analysis of current research and clinical developments within the market. (openpr.com)
Report5
  • To help businesses improve their market position, Technavio's report provides a detailed analysis of around 15+ vendors operating in the market. (countyenews.com)
  • The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. (openpr.com)
  • Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. (openpr.com)
  • The company profiling of leading market players is included this report with Porter's five forces analysis and Value Chain analysis. (openpr.com)
  • Kalorama's report, The Worldwide Market for In Vitro Diagnostics Tests is a comprehensive global report designed to track those activities. (bioinfoinc.com)
Analysis1
  • Advances in liquid biopsy technologies will foster growth by expanding the number of tumor cells that can be readily extracted for analysis. (kaloramainformation.com)
Challenges1
  • There are challenges in the market too, including lab consolidation and government reimbursement reductions, which is why companies often have to partner and combine to survive. (bioinfoinc.com)
Prevalence2
  • Growing prevalence of rare genetic conditions is driving the market growth. (growthmarketreports.com)
  • The increasing prevalence of chronic diseases is one of the most critical factors driving the growth of the market. (theinsightpartners.com)
Technology1
  • However, the regulatory framework for approvals has always posed major restraints on the growth rate of the pharmaceutical, biotechnology, and medical technology industries. (grandviewresearch.com)
Billion2
  • It is a $69.2 billion-dollar market, with lots of players. (bioinfoinc.com)
  • According to the UN Population Division, the global aging population is set to increase from 880 million in 2011 to 2 billion by 2050, representing 22% of the world's population. (meticulousresearch.com)
Tests4
  • The integration of biomarkers and the availability of biomolecular tools are expected to help develop a new range of condition-specific tests, thus creating new opportunities for the IVD market. (jaipurherald.in)
  • Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. (jaipurherald.in)
  • For the next several years, the liquid biopsy market is expected to be driven primarily by tests that detect mutations significant to targeted therapy selection. (kaloramainformation.com)
  • The increasing adoption of rapid tests and point-of-care (PoC) testing for drug monitoring and alcohol abuse is acting as another major growth-inducing factor. (postingtree.com)
Players5
  • The rising number of IVD (in vitro diagnostics ) products being launched by key players is also fueling the growth of the market. (grandviewresearch.com)
  • The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. (openpr.com)
  • Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market. (openpr.com)
  • The adoption rate of pharmacogenomics-based cancer treatment is rising continuously, and the leading market players are introducing several novel products associated with this approach. (theinsightpartners.com)
  • Moreover, market players witnessed disruption in their business operations. (theinsightpartners.com)
Revenue1
  • over the past 5 years, it has averaged revenue growth of 19% annually. (clpmag.com)
Factors1
  • Factors such as the high incidence of a drugs overdose and the adoption of acetaminophen testing drive the market growth. (theinsightpartners.com)